Giant adrenal tumor presenting as Cushing's syndrome and pheochromocytoma: A case report

摘要
参考文献
相关文章
推荐阅读
Metrics

下载:

PDF (1394KB)
输出: BibTeX | EndNote (RIS)

摘要 We report a case of a 35-year-old lady who presented with Cushingoid features and associated raised urinary metanephrine. The patient underwent open adrenelectomy. Histopathological examination revealed adreno-cortical carcinoma with microscopic lymphovascular invasion. Postoperative period was uneventful and is on follow-up for the last one year and is doing well.

	服务
	把本文推荐给朋友
	加入引用管理器
	E-mail Alert
	RSS
	（）
	作者相关文章
	Puskal Kumar Bagchi
	Somor Jyoti Bora
	Sasanka Kumar Barua
	Rajeev Thekumpadam Puthenveetil

关键词: Giant adrenal tumor Cushing's syndrome Pheochromocytoma

Abstract: We report a case of a 35-year-old lady who presented with Cushingoid features and associated raised urinary metanephrine. The patient underwent open adrenelectomy. Histopathological examination revealed adreno-cortical carcinoma with microscopic lymphovascular invasion. Postoperative period was uneventful and is on follow-up for the last one year and is doing well.

Key words: Giant adrenal tumor Cushing's syndrome Pheochromocytoma

收稿日期: 2015-01-27 修回日期: 2015-06-13 出版日期: 2015-07-01 发布日期: 2015-09-18 整期出版日期: 2015-07-01

通讯作者: Puskal Kumar Bagchi E-mail: puskalbagchi@yahoo.co.in

引用本文:

Puskal Kumar Bagchi, Somor Jyoti Bora, Sasanka Kumar Barua, Rajeev Thekumpadam Puthenveetil. Giant adrenal tumor presenting as Cushing's syndrome and pheochromocytoma: A case report[J]. Asian Journal of Urology, 2015, 2(3): 182-184.
Puskal Kumar Bagchi, Somor Jyoti Bora, Sasanka Kumar Barua, Rajeev Thekumpadam Puthenveetil. Giant adrenal tumor presenting as Cushing's syndrome and pheochromocytoma: A case report. Asian Journal of Urology, 2015, 2(3): 182-184.

链接本文:

http://www.ajurology.com/CN/ 或 http://www.ajurology.com/CN/Y2015/V2/I3/182

[1]	National Institutes of Health. NIH state-of-the science statement on management of the clinically inapparent adrenal mass ('incidentaloma'). NIH Consens State Sci Statements 2002;19:1-15.
[2]	Wajchenberg B, Albergaria PM, Medonca B, Latronico A, Campos CP, Ferreira AV, et al. Adrenocortical carcinoma:clinical and laboratory observations. Cancer 2000;88:711-16.
[3]	Koschker AK, Fassnacht M, Hahner S, Weismann D, Allolio B. Adrenocortical carcinoma improving patient care by establishing new structures. Exp Clin Endocrinol Diabetes 2006;144:45-51.
[4]	Wooten MD, King DK. Adrenal cortical carcinoma. Epidemiology and treatment with mitotane and a review of the literature. Cancer 1993;72:3145-55.
[5]	Icard P, Goudet P, Charpenay C, Andreassian B, Carnaille B, Chapuis Y, et al. Adrenocortical carcinomas:surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons Study Group. World J Surg 2001;25:891-1.
[6]	Ramzi C, Vinay K, Tucker C. Robbins and Cotran Pathologic Basis of Disease. London:WB Saunders; 1999.
[7]	Clark S, Orlo P, Komminoth P, Roth J, Schroder S. Endocrine tumours. New York:American Cancer Society Atlas of Oncology Series. Decker; 2003.
[8]	Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA. CampbelleWalsh urology. 10th ed. Elsevier Medicine; 2011. p. 1715. table 57-75.
[9]	Bertherat J, Bertagna X. Pathogenesis of adrenocortical cancer. Best Pract Res Clin Endocrinol Metab 2009;23:261-11.
[10]	Fauci A, Braunwald E, Kasper D, Hauser S, editors. Harrison's principles of internal medicine. Philadelphia:Mc Graw Hill; 2008.

No related articles found!

[1]	Zhixiang Wang, Bing Liu, Xiaofeng Gao, Yi Bao, Yang Wang, Huamao Ye, Yinghao Sun, Linhui Wang. Laparoscopic ureterolysis with simultaneous ureteroscopy and percutaneous nephroscopy for treating complex ureteral obstruction after failed endoscopic intervention: A technical report[J]. Asian Journal of Urology, 2015, 2(4): 238 -243 .
[2]	Louis R. Kavoussi. News from leading international academic urology departments[J]. Asian Journal of Urology, 2017, 4(1): 1 -2 .
[3]	Rikiya Taoka, Yoshiyuki Kakehi. The influence of asymptomatic inflammatory prostatitis on the onset and progression of lower urinary tract symptoms in men with histologic benign prostatic hyperplasia[J]. Asian Journal of Urology, 2017, 4(3): 158 -163 .
[4]	Cheuk Fan Shum, Weida Lau, Chang Peng Colin Teo. Medical therapy for clinical benign prostatic hyperplasia:a1 Antagonists, 5a reductase inhibitors and their combination[J]. Asian Journal of Urology, 2017, 4(3): 185 -190 .
[5]	Foo Keong Tatt. Current consensus and controversies on male LUTS/BPH (part two)[J]. Asian Journal of Urology, 2018, 5(1): 8 -9 .
[6]	Rishi R. Sekar, Claire M. De La Calle, Dattatraya Patil, Sarah A. Holzman, Yoram Baum, Umer Sheikh, Jonathan H. Huang, Adeboye O. Osunkoya, Brian P. Pollack, Haydn T. Kissick, Kenneth Ogan, Viraj A. Master. Major histocompatibility complex I upregulation in clear cell renal cell carcinoma is associated with increased survival[J]. Asian Journal of Urology, 2016, 3(2): 75 -81 .
[7]	Ryan Yu, Jefferson Terry, Mutaz Alnassar, Jorge Demaria. Pediatric fibrous pseudotumor of the tunica vaginalis testis[J]. Asian Journal of Urology, 2016, 3(2): 99 -102 .
[8]	Aso Omer Rashid, Saman Salih Fakhulddin. Risk factors for fever and sepsis after percutaneous nephrolithotomy[J]. Asian Journal of Urology, 2016, 3(2): 82 -87 .
[9]	Christopher Hartman, Nikhil Gupta, David Leavitt, David Hoenig, Zeph Okeke, Arthur Smith. Advances in percutaneous stone surgery[J]. Asian Journal of Urology, 2015, 2(1): 26 -32 .
[10]	Aldamanhori Reem,I.Osman Nadir,R.Chapple Christopher. Underactive bladder: Pathophysiology and clinical significance[J]. Asian Journal of Urology, 2018, 5(1): 17 -21 .

Viewed

Full text

Abstract

Cited

Shared

Discussed